Good evening, ladies and gentlemen, and welcome to the Verrica Pharmaceuticals’ First Quarter 2025 Corporate Update Conference Call. At this time, all participants are in a listen-only mode. After the ...
SUNNYVALE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- BioCardia ®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results